143 related articles for article (PubMed ID: 34846081)
1. Comprehensive analyses of microRNA and mRNA expression in colorectal serrated lesions and colorectal cancer with a microsatellite instability phenotype.
Sugai T; Osakabe M; Niinuma T; Eizuka M; Tanaka Y; Yamada S; Yanagawa N; Otsuka K; Sasaki A; Matsumoto T; Suzuki H
Genes Chromosomes Cancer; 2022 Mar; 61(3):161-171. PubMed ID: 34846081
[TBL] [Abstract][Full Text] [Related]
2. Genome-Wide Analysis of microRNA and mRNA Expression in Colorectal Intramucosal Neoplasia and Colorectal Cancer With a Microsatellite-Stable Phenotype Based on Adenoma-Carcinoma Sequences.
Sugai T; Osakabe M; Niinuma T; Sugimoto R; Eizuka M; Tanaka Y; Yanagawa N; Otsuka K; Sasaki A; Matsumoto T; Suzuki H
Front Oncol; 2022; 12():831100. PubMed ID: 35875068
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of negatively correlated miRNA-mRNA regulatory pairs associated with microsatellite instability in colorectal cancer.
Liu C; Zou X; Song G; Fan X; Peng S; Zhang S; Geng X; Zhou X; Wang T; Cheng W; Zhu W
Cancer Biomark; 2022; 34(3):471-483. PubMed ID: 35253734
[TBL] [Abstract][Full Text] [Related]
4. NTRK oncogenic fusions are exclusively associated with the serrated neoplasia pathway in the colorectum and begin to occur in sessile serrated lesions.
Kim JH; Hong JH; Choi YL; Lee JA; Seo MK; Lee MS; An SB; Sung MJ; Cho NY; Kim SS; Shin YK; Kim S; Kang GH
J Pathol; 2021 Dec; 255(4):399-411. PubMed ID: 34402529
[TBL] [Abstract][Full Text] [Related]
5. IGF2 differentially methylated region hypomethylation in relation to pathological and molecular features of serrated lesions.
Naito T; Nosho K; Ito M; Igarashi H; Mitsuhashi K; Yoshii S; Aoki H; Nomura M; Sukawa Y; Yamamoto E; Adachi Y; Takahashi H; Hosokawa M; Fujita M; Takenouchi T; Maruyama R; Suzuki H; Baba Y; Imai K; Yamamoto H; Ogino S; Shinomura Y
World J Gastroenterol; 2014 Aug; 20(29):10050-61. PubMed ID: 25110432
[TBL] [Abstract][Full Text] [Related]
6. Colorectal tumor molecular phenotype and miRNA: expression profiles and prognosis.
Slattery ML; Herrick JS; Mullany LE; Wolff E; Hoffman MD; Pellatt DF; Stevens JR; Wolff RK
Mod Pathol; 2016 Aug; 29(8):915-27. PubMed ID: 27198570
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of microRNA expression during the progression of colorectal tumors.
Eizuka M; Osakabe M; Sato A; Fujita Y; Tanaka Y; Otsuka K; Sasaki A; Matsumoto T; Suzuki H; Sugai T
Pathol Int; 2020 Sep; 70(9):633-643. PubMed ID: 32592277
[TBL] [Abstract][Full Text] [Related]
8. Association of microRNA-31 with BRAF mutation, colorectal cancer survival and serrated pathway.
Nosho K; Igarashi H; Nojima M; Ito M; Maruyama R; Yoshii S; Naito T; Sukawa Y; Mikami M; Sumioka W; Yamamoto E; Kurokawa S; Adachi Y; Takahashi H; Okuda H; Kusumi T; Hosokawa M; Fujita M; Hasegawa T; Okita K; Hirata K; Suzuki H; Yamamoto H; Shinomura Y
Carcinogenesis; 2014 Apr; 35(4):776-83. PubMed ID: 24242331
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions.
Ito M; Mitsuhashi K; Igarashi H; Nosho K; Naito T; Yoshii S; Takahashi H; Fujita M; Sukawa Y; Yamamoto E; Takahashi T; Adachi Y; Nojima M; Sasaki Y; Tokino T; Baba Y; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
Int J Cancer; 2014 Dec; 135(11):2507-15. PubMed ID: 24752710
[TBL] [Abstract][Full Text] [Related]
10. Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway.
Ito M; Kanno S; Nosho K; Sukawa Y; Mitsuhashi K; Kurihara H; Igarashi H; Takahashi T; Tachibana M; Takahashi H; Yoshii S; Takenouchi T; Hasegawa T; Okita K; Hirata K; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
Int J Cancer; 2015 Sep; 137(6):1258-68. PubMed ID: 25703934
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide analysis of mRNA expression identified the involvement of trefoil factor 1 in the development of sessile serrated lesions.
Sugai T; Osakabe M; Eizuka M; Tanaka Y; Yamada S; Yanagawa N; Matsumoto T; Suzuki H
Pathol Res Pract; 2022 Aug; 236():153987. PubMed ID: 35749918
[TBL] [Abstract][Full Text] [Related]
12. Identifying microRNA-mRNA regulatory network in colorectal cancer by a combination of expression profile and bioinformatics analysis.
Fu J; Tang W; Du P; Wang G; Chen W; Li J; Zhu Y; Gao J; Cui L
BMC Syst Biol; 2012 Jun; 6():68. PubMed ID: 22703586
[TBL] [Abstract][Full Text] [Related]
13. Relationship between
Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE
World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580
[TBL] [Abstract][Full Text] [Related]
14. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
Kim JH; Bae JM; Cho NY; Kang GH
Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
[TBL] [Abstract][Full Text] [Related]
15. The serrated neoplasia pathway of colorectal tumors: Identification of MUC5AC hypomethylation as an early marker of polyps with malignant potential.
Renaud F; Mariette C; Vincent A; Wacrenier A; Maunoury V; Leclerc J; Coppin L; Crépin M; Van Seuningen I; Leteurtre E; Buisine MP
Int J Cancer; 2016 Mar; 138(6):1472-81. PubMed ID: 26476272
[TBL] [Abstract][Full Text] [Related]
16. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.
Christensen LL; Tobiasen H; Holm A; Schepeler T; Ostenfeld MS; Thorsen K; Rasmussen MH; Birkenkamp-Demtroeder K; Sieber OM; Gibbs P; Lubinski J; Lamy P; ; Laurberg S; Oster B; Hansen KQ; Hagemann-Madsen R; Byskov K; Ørntoft TF; Andersen CL
Int J Cancer; 2013 Jul; 133(1):67-78. PubMed ID: 23280316
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide analysis of mRNA and microRNA expression in colorectal cancer and adjacent normal mucosa.
Ito Y; Osakabe M; Niinuma T; Uesugi N; Sugimoto R; Yanagawa N; Otsuka K; Sasaki A; Matsumoto T; Suzuki H; Sugai T
J Pathol Clin Res; 2022 Jul; 8(4):313-326. PubMed ID: 35285580
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes.
Schepeler T; Holm A; Halvey P; Nordentoft I; Lamy P; Riising EM; Christensen LL; Thorsen K; Liebler DC; Helin K; Ørntoft TF; Andersen CL
Oncogene; 2012 May; 31(22):2750-60. PubMed ID: 21963845
[TBL] [Abstract][Full Text] [Related]
19. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
20. The spectrum of serrated colorectal lesions-new entities and unanswered questions.
Bateman AC
Histopathology; 2021 May; 78(6):780-790. PubMed ID: 33332664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
